Thu, Apr 27, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Law firm advises on likely impact for fund managers of a country leaving the Eurozone

Friday, June 15, 2012

Beverly Chandler, Opalesque London: Partners at law firm Dechert have addressed the issue of how a Eurozone event such as the exit of a country from the Eurozone would affect investment managers. As the news grows increasingly gloomy on the likely continuation of the Eurozone in its current state, Dechert urges fund managers to anticipate the impact of such an exit and to plan the steps they would need to take in response to such a development. "Managing this risk includes short and medium term steps to reduce risk or exposure, as well as the action that would need to be taken on the occurrence of an actual Eurozone event" the firm says.

Potential issues and oversight actions that should be considered by the management and boards of US and non-US funds include:

  • What are likely to be the key issues from the Euro Crisis that could impact U.S. Registered Funds, UCITs and QIFs/SIFs; in particular, what boards should consider, analysis of fund documentation, risk management, portfolio and share class exposure, investment management agreements, service provider and counterparty agreements, custody arrangements and liquidity and valuation;
  • What are the ways that fund managers can be proactive to prepare to deal with the Euro Crisis;
  • Applying the lessons learned from the 2007-2008 financial crisis to the issues arising from the Euro Crisis;
Risks relating specifically to currency redenomination include market closures; mandatory bank holidays; restricti......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V